QGEN - Utang jangka cendhak marang modal Qiagen N.V.

QGEN (Qiagen N.V.) - tandha merek perusahaan

The short-term debt-to-equity ratio on the GURU.Markets chart correlates with the effective global distribution of reagents by Qiagen N.V. (QGEN). The value 0.01 describes the current level of debt load supported by plant capacities in the US and Germany. Business resilience is ensured by patent protection and the deep integration of test systems into clinics, which creates significant barriers to entry for new market players.

Tanggungan utang jangka cendhak marang ekuitas: Qiagen NV (QGEN) kanggo 04.07.2022 - 01.11.2026
Produk merek qiagen.com

Qiagen N.V. is aggressively competing for the laboratory market amid intense pressure from healthcare behemoths. The current value of 0.01 reflects the ratio of short-term liabilities to equity, determining financial stability during equipment procurement. This metric measures the business's dependence on rapid debt repayment to prevent the risk of cash flow gaps. Analyzing the dynamics of short-term loans relative to equity allows for the timely detection of balance sheet strain.

Pesaing Qiagen N.V. (QGEN)

Utang jangka cendhak marang ekuitas Tempus AI (TEM)|Isis Pharmaceuticals - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal RGEN (Repligen Corporation)|Utang jangka cendhak marang modal aviditybiosciences.com RNA|CRSP - Utang jangka cendhak marang ekuitas|Tanggungan utang jangka cendhak marang ekuitas GeneDx Holdings (WGS)|RARE: Utang jangka cendhak marang modal|BEAM - Koefisien utang jangka cendhak marang modal|SRPT (Sarepta Therapeutics, Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal twistbioscience.com|Utang jangka cendhak marang modal TXG|Intellia Therapeutics Inc (NTLA) - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal STOK (Stoke)|BioLife (BLFS) - Kewajiban jangka cendhak marang modal|WVE - Utang jangka cendhak marang ekuitas|MAZE (mazetx.com) - Rasio utang jangka cendhak marang modal|SION (Sionna Therapeutics) - Rasio utang jangka cendhak marang ekuitas|Prime Medicine Inc - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Taysha|Rasio utang jangka cendhak marang modal QURE (uniQure Pharma)|Rasio utang jangka cendhak marang ekuitas MGTX (MeiraGTx Holdings plc)|Koefisien utang jangka cendhak marang modal regenxbio.com|Solid Biosciences - Rasio utang jangka cendhak marang ekuitas|Ocugen Inc - Utang jangka cendhak marang ekuitas|PACB: Rasio utang jangka cendhak marang ekuitas|Koefisien utang jangka cendhak marang modal Benitec Corp BNTC|Design Therapeutics (DSGN) - Utang jangka cendhak marang ekuitas|Tanggungan utang jangka cendhak marang ekuitas rocketpharma.com RCKT|FDMT (4D Molecular Therapeutics, Inc.) - Utang jangka cendhak marang modal|LXEO - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal KRRO|EDIT - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Silence Therapeutics SLN|PRQR: Rasio utang jangka cendhak marang modal|Codexis Bio - Utang jangka cendhak marang modal|SGMO (Sangamo Therapeutics Inc.) - Rasio utang jangka cendhak marang modal|nautilus.bio (NAUT) - Utang jangka cendhak marang ekuitas|Rasio utang jangka cendhak marang modal MGX|DTIL (Precision BioSciences) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Generation Bio Corp|Utang jangka cendhak marang ekuitas Boundless Bio (BOLD)|exicuretx.com (XCUR) - Tanggungan utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal IMNN (Imunon)|Koefisien utang jangka cendhak marang modal Phio Pharmaceuticals Corp (PHIO)|Mustang Bio Corp - Utang jangka cendhak marang modal|RNAZ - Utang jangka cendhak marang modal|BNGO: Utang jangka cendhak marang modal|Tanggungan utang jangka cendhak marang ekuitas Applied DNA Sciences Inc APDN|BLUE (Bluebird Bio) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal ImmunoPrecise IPA|Utang jangka cendhak marang ekuitas Omega Therapeutics (OMGA)|singulargenomics.com - Rasio utang jangka cendhak marang modal|Regulus Therapeutics Inc. - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal SYRS|TBIO - Utang jangka cendhak marang ekuitas|TCON (TRACON Pharmaceuticals, Inc) - Rasio utang jangka cendhak marang modal|UBX (Unity Biotechnology) - Rasio utang jangka cendhak marang ekuitas